[Clinical and functional late results following acute pelvic/leg vein thrombosis in relation to method of treatment]. 1991

C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
Städtisches Klinikum, Krankenhaus Dresden-Friedrichstadt.

UI MeSH Term Description Entries
D011186 Postphlebitic Syndrome A condition characterized by a chronically swollen limb, often a leg with stasis dermatitis and ulcerations. This syndrome can appear soon after phlebitis or years later. Postphlebitic syndrome is the result of damaged or incompetent venous valves in the limbs. Distended, tortuous VARICOSE VEINS are usually present. Leg pain may occur after long period of standing. Postphlebitic Disease,Postphlebitic Ulcer,Disease, Postphlebitic,Diseases, Postphlebitic,Postphlebitic Diseases,Postphlebitic Syndromes,Postphlebitic Ulcers,Syndrome, Postphlebitic,Syndromes, Postphlebitic,Ulcer, Postphlebitic,Ulcers, Postphlebitic
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D014689 Venous Insufficiency Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle. Insufficiencies, Venous,Insufficiency, Venous,Venous Insufficiencies

Related Publications

C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
May 1987, Der Internist,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
January 1988, VASA. Supplementum,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
July 1985, Deutsche medizinische Wochenschrift (1946),
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
June 1976, Die Medizinische Welt,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
September 1972, Die Medizinische Welt,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
June 2001, Zentralblatt fur Chirurgie,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
January 1979, Zeitschrift fur arztliche Fortbildung,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
January 1991, VASA. Supplementum,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
January 1992, VASA. Supplementum,
C Spranger, and E Altmann, and H G Brandl, and P K Schmidt, and J Schweizer
January 1982, Zentralblatt fur Chirurgie,
Copied contents to your clipboard!